1.Incidentally Detected Enhancing Breast Lesions on Chest Computed Tomography.
Wen Chiung LIN ; Hsian He HSU ; Chao Shiang LI ; Jyh Cherng YU ; Giu Cheng HSU ; Cheng Ping YU ; Tsun Hou CHANG ; Guo Shu HUANG
Korean Journal of Radiology 2011;12(1):44-51
OBJECTIVE: To evaluate the nature and imaging appearance of incidental enhancing breast lesions detected on a routine contrast-enhanced chest CT. MATERIALS AND METHODS: Twenty-three patients with incidental enhancing breast lesions on contrast-enhanced chest CT were retrospectively reviewed. The breast lesions were reviewed by unenhanced and enhanced CT, and evaluated by observing the shapes, margins, enhancement patterns and backgrounds of breast lesions. A histopathologic diagnosis or long-term follow-up served as reference standard. RESULTS: Sixteen (70%) patients had malignant breast lesions and seven (30%) had benign lesions. In 10 patients, the breast lesions were exclusively detected on contrast-enhanced CT. Using unenhanced CT, breast lesions with fibroglandular backgrounds were prone to be obscured (p < 0.001). Incidental primary breast cancer showed an non-significant trend of a higher percentage irregular margin (p = 0.056). All of the four incidental breast lesions with non-mass-like enhancement were proven to be malignant. CONCLUSION: Routine contrast-enhanced chest CT can reveal sufficient details to allow for the detection of unsuspected breast lesions, in which some cases may be proven as malignant. An irregular margin of incidental enhancing breast lesion can be considered a suggestive sign of malignancy.
Aged
;
Breast Diseases/radiography
;
Breast Neoplasms/*radiography/secondary
;
*Contrast Media
;
Female
;
Humans
;
*Incidental Findings
;
Iohexol/*analogs & derivatives/diagnostic use
;
Middle Aged
;
*Radiography, Thoracic
;
*Tomography, X-Ray Computed
2.Anti-Melanogenic Effect from Submerged Mycelial Cultures of Ganoderma weberianum
Ying Jang LAI ; Kai Di HSU ; Tzu Jung HUANG ; Chang Wei HSIEH ; Yu Hin CHAN ; Kuan Chen CHENG
Mycobiology 2019;47(1):112-119
Compounds from Lingzhi has been demonstrated the ability for inhibiting tyrosinase (a key enzyme in melanogenesis) activity. In this study, we investigated the anti-melanogenic activity from the submerged mycelial culture of Ganoderma weberianum and elucidated the skin lightening mechanism by B16-F10 murine melanoma cells. From the cellular context, several fractionated mycelium samples exhibited anti-melanogenic activity by reducing more than 40% extracellular melanin content of B16-F10 melanoma cells. In particular, the fractionated chloroform extract (CF-F3) inhibited both secreted and intracellular melanin with the lowest dosage (25 ppm). Further analysis demonstrated that CF-F3 inhibited cellular tyrosinase activity without altering its protein expression. Taken together, our study has demonstrated that the chemical extracts from submerged mycelial culture of G. weberianum have the potential to serve as an alternative anti-melanogenic agent.
Chloroform
;
Ganoderma
;
Melanins
;
Melanoma
;
Monophenol Monooxygenase
;
Mycelium
;
Reishi
;
Skin
3.Peer reviewing of screening mammography in Taiwan: its reliability and the improvement
Huay-Ben PAN ; Giu-Cheng HSU ; Tsung-Lung YANG ; Jer-Shyung HUANG ; Chen-Pin CHOU ; Huei-Lung LIANG ; San-Kan LEE
Chinese Medical Journal 2013;(1):68-71
Background Early detection with screening mammography can potentially reduce breast cancer mortality rates.To achieve an efficient screening,a peer review system provides a compensatory double-check reviewing,will hopefully to prevent the omission of detectable lesions and reduce unnecessary recall.Methods In 2009,4643 initial mammographic screenings reported by 74 screening radiologists had negative results with a recall rate of less than 5%.In the same year,2538 initial positives screened by 18 screening radiologists had a recall rate higher than 15%.Those 7181 randomized screenings were evenly distributed for reassessment by 39 reviewing radiologists.The disagreement of assessments between the reviewers and screening radiologists was recorded.The differential rate was defined as the number of the disagreements divided by the number of audited films reviewed by a screening radiologist.The equality of the differential rates for each screening radiologists with negative and positive assessments was compared by a Chi-square test.The performance of the 39 auditors was measured by the Kendall's tau statistic.P values less than 0.05 were considered statistically significant.Results The mean differential rate for screening radiologists of negative assessments was 6.7% (P=-0.588),while 35.0% for positive assessments were significant (P <0.001).The result indicated that most of the initial negative assessments reported by the screening radiologists were generally accepted by the reviewers but not the positive assessments.With respect to the 39 reviewers,there was no significant evidence for the association of the difference rates between negative and positive assessments.Nine reviewers were found to have their differential rate for negative and positive assessments larger than the average of the population.Eleven reviewers were found to have their differential rates smaller than the average for both.Thirteen reviewers had their differential rates smaller than the average for negative assessments but larger than the average for positive assessments.The opposite condition was found for six reviewers.The Kendall's tau statistic was 0.038 (P=0.735).Conclusions Reviewers usually agreed with the opinion of the initial screening doctors who reported negative findings.Therefore,a 5% recall rate as the lower range of reviewing negatives may be still too high.The recall rate of more than 15% was significantly related to improper interpretation,especially when the differential rate is 25% or higher,a warning to the underperforming screening radiologist is recommended.An ideal reviewer should interpret films independently.Reviewers with tendencies to be followers or contrarians should not be enrolled in the reviewing system.
4.Effects of coffee intake on airway hypersensitivity and immunomodulation:an in vivo murine study
Ying-Chi WONG ; Wen-Cheng HSU ; Tzee-Chung WU ; Ching-Feng HUANG
Nutrition Research and Practice 2023;17(4):631-640
BACKGROUND/OBJECTIVES:
Coffee is a complex chemical mixture, with caffeine being the most well-known bioactive substance. The immunomodulatory and anti-inflammatory properties of coffee and caffeine impact health in various aspects, including the respiratory system. The objective is to investigate the effects of coffee and caffeine on airway hyperresponsiveness and allergic reactions, as well as to analyze and compare associated cytokine profiles.MATERIALS/METHODS: BALB/c mice were intraperitoneally sensitized with ovalbumin (OVA) and given OVA inhalation to induce airway hypersensitivity. Two weeks after sensitization, they were intragastrically gavaged with coffee or caffeine, both containing 0.3125 mg caffeine, daily for 4 weeks. Control mice were fed with double-distilled water. Serum OVAspecific antibody levels were measured beforehand and 5 weeks after the first gavage. Airway hyperresponsiveness was detected by whole body plethysmography after gavage. Cytokine levels of bronchoalveolar lavage and cultured splenocytes were analyzed.
RESULTS:
Coffee effectively suppressed T helper 2-mediated specific antibody response.Airway responsiveness was reduced in mice treated with either coffee or caffeine. Compared to the control, coffee significantly reduced OVA-specific immunoglobulin (Ig) G, IgG1 and IgE antibody responses (P < 0.05). Caffeine also attenuated specific IgG and IgG1 levels, though IgE level was unaffected. Coffee significantly reduced interleukin (IL)-4 and increased IL-10 concentration in spleen cells and bronchoalveolar lavage fluid (P < 0.05).
CONCLUSIONS
Coffee effectively attenuated airway hyperresponsiveness and systemic allergic responses induced by OVA food allergen in mice. As a complex composition of bioactive substances, coffee displayed enhanced immunomodulatory and anti-inflammatory effects than caffeine.
5.Scaling up the in-hospital hepatitis C virus care cascade in Taiwan
Chung-Feng HUANG ; Pey-Fang WU ; Ming-Lun YEH ; Ching-I HUANG ; Po-Cheng LIANG ; Cheng-Ting HSU ; Po-Yao HSU ; Hung-Yin LIU ; Ying-Chou HUANG ; Zu-Yau LIN ; Shinn-Cherng CHEN ; Jee-Fu HUANG ; Chia-Yen DAI ; Wan-Long CHUANG ; Ming-Lung YU
Clinical and Molecular Hepatology 2021;27(1):136-143
Background/Aims:
Obstacles exist in facilitating hepatitis C virus (HCV) care cascade. To increase timely and accurate diagnosis, disease awareness and accessibility, in-hospital HCV reflex testing followed by automatic appointments and a late call-back strategy (R.N.A. model) was applied. We aimed to compare the HCV treatment rate of patients treated with this strategy compared to those without.
Methods:
One hundred and twenty-five anti-HCV seropositive patients who adopted the R.N.A. model in 2020 and another 1,396 controls treated in 2019 were enrolled to compare the gaps in accurate HCV RNA diagnosis to final treatment allocation.
Results:
The HCV RNA testing rate was significantly higher in patients who received reflex testing than in those without reflex testing (100% vs. 84.8%, P<0.001). When patients were stratified according to the referring outpatient department, a significant improvement in the HCV RNA testing rate was particularly noted in patients from non-hepatology departments (100% vs. 23.3%, P<0.001). The treatment rate in HCV RNA seropositive patients was 83% (83/100) after the adoption of the R.N.A. model, among whom 96.1% and 73.9% of patients were from the hepatology and non-hepatology departments, respectively. Compared to subjects without R.N.A. model application, a significant improvement in the treatment rate was observed for patients from non-hepatology departments (73.9% vs. 27.8%, P=0.001). The application of the R.N.A. model significantly increased the in-hospital HCV treatment uptake from 6.4% to 73.9% for patients from non-hepatology departments (P<0.001).
Conclusions
The care cascade increased the treatment uptake and set up a model for enhancing in-hospital HCV elimination.
6.Risks of cervical intraepithelial neoplasia grade 3 or invasive cancers in ASCUS women with different management: a population-based cohort study.
Yi Jou TAI ; Yun Yuan CHEN ; Huang Cheng HSU ; Chun Ju CHIANG ; San Lin YOU ; Chi An CHEN ; Wen Fang CHENG
Journal of Gynecologic Oncology 2018;29(4):e55-
OBJECTIVE: To investigate the progression risk of atypical squamous cells of undetermined significance (ASCUS) with different clinical managements. METHODS: Women with their first diagnosis of ASCUS cytology were retrieved from the national cervical cancer screening database and linked to the national health insurance research database to identify the management of these women. The incidences of developing cervical intraepithelial neoplasia grade 3 and invasive cervical cancer (CIN3+) were calculated, and the hazard ratios (HRs) were estimated using a Cox proportional hazards model. This study was approved by the Research Ethics Committee of the National Taiwan University Hospital and is registered at ClinicalTrials.gov (Identifier: NCT02063152). RESULTS: There were total 69,741 women included. Various management strategies including colposcopy, cervical biopsies and/or endocervical curettage, and cryotherapy, failed to reduce the risk of subsequent CIN3+ compared with repeat cervical smears. Loop electrosurgical excision procedure/conization significantly decreased risk of subsequent CIN3+ lesions (HR=0.22; 95% confidence interval [CI]=0.07–0.68; p=0.010). Women in their 40s–50s had an approximately 30% risk reduction compared to other age groups. Women with a previous screening history >5 years from the present ASCUS diagnosis were at increased risk for CIN3+ (HR=1.24; 95% CI=1.03–1.49; p=0.020). CONCLUSION: In women of first-time ASCUS cytology, a program of repeat cytology can be an acceptable clinical option in low-resource settings. Caution should be taken especially in women with remote cervical screening history more than 5 years.
Atypical Squamous Cells of the Cervix*
;
Biopsy
;
Cervical Intraepithelial Neoplasia*
;
Cohort Studies*
;
Colposcopy
;
Cryotherapy
;
Curettage
;
Diagnosis
;
Ethics Committees, Research
;
Female
;
Humans
;
Incidence
;
Mass Screening
;
National Health Programs
;
Proportional Hazards Models
;
Risk Reduction Behavior
;
Taiwan
;
Uterine Cervical Neoplasms
;
Vaginal Smears
7.Indoxyl sulfate, homocysteine, and antioxidant capacities in patients at different stages of chronic kidney disease
Cheng-Hsu CHEN ; Shih-Chien HUANG ; En-Ling YEH ; Pei-Chih LIN ; Shang-Feng TSAI ; Yi-Chia HUANG
Nutrition Research and Practice 2022;16(4):464-475
BACKGROUND/OBJECTIVES:
Increased levels of uremic toxins and decreased antioxidant capacity have a significant impact on the progression of chronic kidney disease (CKD). However, it remains unclear whether they interact with each other to mediate the damage of kidney function. The purpose of this study was to investigate whether uremic toxins (i.e., homocysteine and indoxyl sulfate [IS]), as well as glutathione-dependent antioxidant enzyme activities are dependently or independently associated with kidney function during different stages of CKD patients.
SUBJECTS/METHODS:
One hundred thirty-two patients diagnosed with CKD at stages 1 to 5 participated in this cross-sectional study.
RESULTS:
Patients who had reached an advanced CKD stage experienced an increase in plasma uremic toxin levels, along with decreased glutathione peroxidase (GSH-Px) activity.Plasma homocysteine, cysteine, and IS concentrations were all positively associated with each other, but negatively correlated to GSH-Px activity levels after adjusting for potential confounders in all CKD patients. Although plasma homocysteine, cysteine, IS, and GSHPx levels were significantly associated with kidney function, only plasma IS levels still had a significant association with kidney function after these parameters were simultaneously adjusted. In addition, plasma IS could interact with GSH-Px activity to be associated with kidney function.
CONCLUSIONS
IS plays a more dominant role than homocysteine and GSH-Px activity in relation to kidney function.
8.Comedications and potential drug-drug interactions with direct-acting antivirals in hepatitis C patients on hemodialysis
Po-Yao HSU ; Yu-Ju WEI ; Jia-Jung LEE ; Sheng-Wen NIU ; Jiun-Chi HUANG ; Cheng-Ting HSU ; Tyng-Yuan JANG ; Ming-Lun YEH ; Ching-I HUANG ; Po-Cheng LIANG ; Yi-Hung LIN ; Ming-Yen HSIEH ; Meng-Hsuan HSIEH ; Szu-Chia CHEN ; Chia-Yen DAI ; Zu-Yau LIN ; Shinn-Cherng CHEN ; Jee-Fu HUANG ; Jer-Ming CHANG ; Shang-Jyh HWANG ; Wan-Long CHUANG ; Chung-Feng HUANG ; Yi-Wen CHIU ; Ming-Lung YU
Clinical and Molecular Hepatology 2021;27(1):186-196
Background/Aims:
Direct‐acting antivirals (DAAs) have been approved for hepatitis C virus (HCV) treatment in patients with end-stage renal disease (ESRD) on hemodialysis. Nevertheless, the complicated comedications and their potential drug-drug interactions (DDIs) with DAAs might limit clinical practice in this special population.
Methods:
The number, class, and characteristics of comedications and their potential DDIs with five DAA regimens were analyzed among HCV-viremic patients from 23 hemodialysis centers in Taiwan.
Results:
Of 2,015 hemodialysis patients screened in 2019, 169 patients seropositive for HCV RNA were enrolled (mean age, 65.6 years; median duration of hemodialysis, 5.8 years). All patients received at least one comedication (median number, 6; mean class number, 3.4). The most common comedication classes were ESRD-associated medications (94.1%), cardiovascular drugs (69.8%) and antidiabetic drugs (43.2%). ESRD-associated medications were excluded from DDI analysis. Sofosbuvir/velpatasvir/voxilaprevir had the highest frequency of potential contraindicated DDIs (red, 5.6%), followed by glecaprevir/pibrentasvir (4.0%), sofosbuvir/ledipasvir (1.3%), sofosbuvir/velpatasvir (1.3%), and elbasvir/grazoprevir (0.3%). For potentially significant DDIs (orange, requiring close monitoring or dose adjustments), sofosbuvir/velpatasvir/voxilaprevir had the highest frequency (19.9%), followed by sofosbuvir/ledipasvir (18.2%), glecaprevir/pibrentasvir (12.6%), sofosbuvir/velpatasvir (12.6%), and elbasvir/grazoprevir (7.3%). Overall, lipid-lowering agents were the most common comedication class with red-category DDIs to all DAA regimens (n=62), followed by cardiovascular agents (n=15), and central nervous system agents (n=10).
Conclusions
HCV-viremic patients on hemodialysis had a very high prevalence of comedications with a broad spectrum, which had varied DDIs with currently available DAA regimens. Elbasvir/grazoprevir had the fewest potential DDIs, and sofosbuvir/velpatasvir/voxilaprevir had the most potential DDIs.
9.An Unusual Radiologic Pattern of Cryptogenic Organizing Pneumonia: Diffuse Pulmonary Nodules in a Leukemia Patient.
Kai Hsiung KO ; Hsian He HSU ; Woei Yau KAO ; Ching Feng CHANG ; Ming Fang CHENG ; Guo Shu HUANG
Korean Journal of Radiology 2009;10(1):93-96
The radiological appearance of diffuse discrete pulmonary nodules associated with cryptogenic organizing pneumonia (COP) has been rarely described. We describe a case of COP in 49-year-old woman with acute myeloid leukemia who developed diffuse pulmonary nodules during the second course of induction chemotherapy. The clinical status of the patient and imaging findings suggested the presence of a pulmonary metastasis or infectious disease. A video-assisted thoracoscopic lung biopsy resulted in the unexpected diagnosis of COP as an isolated entity. Steroid therapy led to dramatic improvement of the clinical symptoms and the pulmonary lesions.
Cryptogenic Organizing Pneumonia/complications/*radiography
;
Diagnosis, Differential
;
Female
;
Humans
;
Leukemia, Myeloid, Acute/*complications/pathology
;
Lung/*radiography
;
Lung Neoplasms/radiography/secondary
;
Middle Aged
;
Multiple Pulmonary Nodules/complications/*radiography
10.Peer reviewing of screening mammography in Taiwan: its reliability and the improvement.
Huay-ben PAN ; Giu-cheng HSU ; Tsung-lung YANG ; Jer-shyung HUANG ; Chen-pin CHOU ; Huei-lung LIANG ; San-kan LEE ; Yi-hong CHOU ; Hung-ju LI ; Kam-fai WONG
Chinese Medical Journal 2013;126(1):68-71
BACKGROUNDEarly detection with screening mammography can potentially reduce breast cancer mortality rates. To achieve an efficient screening, a peer review system provides a compensatory double-check reviewing, will hopefully to prevent the omission of detectable lesions and reduce unnecessary recall.
METHODSIn 2009, 4643 initial mammographic screenings reported by 74 screening radiologists had negative results with a recall rate of less than 5%. In the same year, 2538 initial positives screened by 18 screening radiologists had a recall rate higher than 15%. Those 7181 randomized screenings were evenly distributed for reassessment by 39 reviewing radiologists. The disagreement of assessments between the reviewers and screening radiologists was recorded. The differential rate was defined as the number of the disagreements divided by the number of audited films reviewed by a screening radiologist. The equality of the differential rates for each screening radiologists with negative and positive assessments was compared by a Chi-square test. The performance of the 39 auditors was measured by the Kendall's tau statistic. P values less than 0.05 were considered statistically significant.
RESULTSThe mean differential rate for screening radiologists of negative assessments was 6.7% (P = 0.588), while 35.0% for positive assessments were significant (P < 0.001). The result indicated that most of the initial negative assessments reported by the screening radiologists were generally accepted by the reviewers but not the positive assessments. With respect to the 39 reviewers, there was no significant evidence for the association of the difference rates between negative and positive assessments. Nine reviewers were found to have their differential rate for negative and positive assessments larger than the average of the population. Eleven reviewers were found to have their differential rates smaller than the average for both. Thirteen reviewers had their differential rates smaller than the average for negative assessments but larger than the average for positive assessments. The opposite condition was found for six reviewers. The Kendall's tau statistic was 0.038 (P = 0.735).
CONCLUSIONSReviewers usually agreed with the opinion of the initial screening doctors who reported negative findings. Therefore, a 5% recall rate as the lower range of reviewing negatives may be still too high. The recall rate of more than 15% was significantly related to improper interpretation, especially when the differential rate is 25% or higher, a warning to the underperforming screening radiologist is recommended. An ideal reviewer should interpret films independently. Reviewers with tendencies to be followers or contrarians should not be enrolled in the reviewing system.
Breast Neoplasms ; diagnostic imaging ; Early Detection of Cancer ; Female ; Humans ; Mammography ; Peer Review ; Reproducibility of Results ; Taiwan